Skip to main content

Advertisement

Table 2 Seropositivity at baseline

From: Systematic review of dengue vaccine efficacy

Study Seropositivity of the vaccine group* Seropositivity of the control group*
Dayan (2013) 69% 71%
Villar (2013) 75% 78%
Tran (2012) 71% 67%
Lanata (2012) 37% 48%
Sabchareon (2012) 70% 69%
Capeding (2014)** 68% 67%
Villar (2015)** 81% 77%
  1. *Seropositivity of the participants at baseline
  2. **Seropositivity was searched in the reactogenicity and immunogenicity subgroups, not in all participants